AEON Biopharma Inc. (AEON) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AEON Biopharma Inc.

    NASDAQ: AEON · Real-Time Price · USD
    0.81
    -0.01 (-0.67%)
    At close: Oct 03, 2025, 3:57 PM
    0.81
    0.00%
    Pre-market: Oct 06, 2025, 04:18 AM EDT

    AEON Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q2 2023 Q1 2023 Q4 2022 Q3 2022
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Income
    		 -4.34M -462K -2.32M -4.02M 153.47M -74.15M -13.97M -13.05M -15.03M -9.91M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -6.64M 9.1M 2.08M -6.17M 164.11M -118.02M -15.38M -17.64M -34.56M -10.44M
    Net Income
    		 -6.64M 9.1M 2.08M -6.17M 164.11M -118.02M -15.38M -17.64M -34.56M -10.44M
    Selling & General & Admin
    		 3.26M 3.13M 2.63M 3.04M 3.32M 4.65M 4.95M 3.84M 5.5M 2.44M
    Research & Development
    		 1.06M 825K 3.04M 972K 4.44M 5.73M 9.03M 9.21M 9.53M 7.48M
    Other Expenses
    		 16K -3.49M -3.35M n/a -161.23M 63.77M n/a n/a n/a n/a
    Operating Expenses
    		 4.34M 462K 2.32M 4.02M -153.47M 74.15M 13.97M 13.05M 15.03M 9.91M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 4.34M 462K 2.32M 4.02M -153.47M 74.15M 13.97M 13.05M 15.03M 9.91M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a -16.58K -22.88K -27.08K
    Shares Outstanding (Basic)
    		 11.09M 3.98M 554.26K n/a 539.49K 37.27M 380.98K 22M n/a 22M
    Shares Outstanding (Diluted)
    		 11.09M 3.98M 555.34K n/a 539.49K 37.27M 380.98K 22M n/a 22M
    EPS (Basic)
    		 -0.6 2.28 3.76 n/a 303.84 -227.87 -40.37 -0.8 n/a -0.47
    EPS (Diluted)
    		 -0.6 2.28 3.75 n/a 303.84 -227.87 -40.37 -0.8 n/a -0.47
    EBITDA
    		 -4.3M -3.93M -5.64M -3.99M -7.74M -10.36M -13.95M -13.02M -15M -9.91M
    EBIT
    		 -4.32M -3.95M -5.67M -4.02M -7.76M -10.38M -13.97M -13.05M -15.03M -9.91M
    Depreciation & Amortization
    		 20K 19K 23K 25K 24K 25K 23K 25K 32K 27.08K

    Add to Watchlist